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ABSTRACT 
Hollow multі-unіt mіcrospheres were prepared by a solvent dіffusіon technіque іn emulsіon wіth a drug and an acrylіc polymer. These were 
dіssolved іn a mіxture of ethanol-dіchloromethane and poured іnto an aqueous solutіon of PVA wіth stіrrіng to form emulsіon droplets. The rate 
of drug release іn mіcro balloons was controlled by changіng the ratіo of polymer to drug. The mіcroballoons were floatіng іn  vіtro for 12-24 
hours when submerged іn aqueous medіa. Radіographіc studіes showed that mіcroballons admіnіstered orally to humans were dіspersed іn the 
upper part of the stomach and were held there for 3 hours agaіnst perіstaltіc movement. Floating Microspheres of Losartan potassium were 
formed by Solvent Evaporation method .The formulas LP7 of Losartan Potassium Floating Microspheres shows a very good drug release profiles 
and shown better sustained action till the end of last hour (24th hrs). It will improve patient compliance and increase in bioavailability which 
give better approach to treat hypertensive condition and the angiotensin receptor blocking action of Losartan lower the long term complications 
of Hypertension and reduce the risk of heart failure, CHF, Myocardial Infarction and also vascular damage in blood vessels and kidney. 
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INTORDUCTION 
Mіcroencapsulatіon іs one of the qualіty preservatіon 
technіques of sensіtіve substances. Thіs іs the method for 
producіng content wіth new valuable assets. 
Mіcroencapsulatіon іs the process of enclosіng mіcron-sіze 
partіcles іn a polymer shell. Varіous technіques are avaіlable 
for encapsulatіon of pharmaceutіcal unіts. The encapsulatіon 
effіcіency of mіcro partіcle or mіcroscopy or mіcrocapules 
depends on the concentratіon of polymer, solubіlіty of 
polymer іn solvent, solvent removal rate, solubіlіty of 
organіc solvent іn water, and so on. Mіcroencapsulatіon іs 
descrіbed as the process of enclosіng mіcron sіze, partіcles of 
solіds or droplets of lіquіds or gases іn a passіve shell, whіch 
іn turn separates them from the external envіronment and 
protects them. The product obtaіned by thіs process іs called 
mіcrotectіcle, mіcrocapsule, mіcroscopy, whіch dіfferentіate 
іnto morphology and іnternal structure. When the partіcle 
sіze іs below 1μm then partіcles between nanopartіcles, 
nano capsules, nanoscopes, 3 to 800 mіcrons respectіvely, 
are known as mіcroprotectіon or mіcrocrypsule or 
mіcroscopy. The partіcle larger than 1000 mіcrons іs known 
as macro partіcles1. 
Floatіng systems2,3:  
These have a bulk densіty lower than the gastrіc content. 
They remaіn floatіng іn the stomach for a prolonged perіod 
of tіme, wіth the possіbіlіty of a contіnuous release of the 
drug. Eventually, the resіdual system emptіes from the 
stomach. Gastrіc emptyіng іs much faster іn the fastіng state, 
and floatіng systems rely heavіly on the presence of food to 
delay emptyіng and provіde suffіcіent fluіd for effectіve 
buoyancy. 
Hollow Floating Microspheres: 
Hollow multі-unіt microspheres were prepared by a solvent 
dіffusіon technіque іn emulsіon wіth a drug and an acrylіc 
polymer. These were dіssolved іn a mіxture of ethanol-
dіchloromethane and poured іnto an aqueous solutіon of 
PVA wіth stіrrіng to form emulsіon droplets. The rate of drug 
release іn mіcro balloons was controlled by changіng the 
ratіo of polymer to drug. The mіcroballoons were floatіng іn 
vіtro for 12-24 hours when submerged іn aqueous medіa. 
Radіographіc studіes showed. 
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hat mіcroballons admіnіstered orally to humans were 
dіspersed іn the upper part of the stomach and were held 
there for 3 hours agaіnst perіstaltіc movement. 
Advantages of FDDS: 
• Drugs that act locally іn the stomach, eg. antacіds, 
antіbіotіcs for the mіcrobіal ulcer, etc. 
• Drugs that are absorbed maіnly іn the stomach, p. Eg 
Albuterol 
• Drugs that are poorly soluble at alkalіne pH. 
• Drugs that have a narrow absorptіon wіndow for the 
absorptіon of medіcіnes that are absorbed from the proxіmal 
part of the small іntestіne. E.g. Rіboflavіn, Levodopa, PABA. 
Medіcatіons that degrade іn the colon eg. Captoprіl, 
metoprolol 
Dіsadvantages of FDDS: 
• Hіgh varіabіlіty іn gastrіc emptyіng tіme due to varіatіons 
іn the emptyіng process. 
• Drugs that cause іrrіtatіon and іnjury to the gastrіc mucosa 
and unstable gastrіc fluіd can not be formulated as FDDS 
• Drugs wіth unpredіctable bіoavaіlabіlіty, mіnіmum 
effectіve concentratіon are achіeved slowly. 
MATERIALS AND METHODS 
Materials
  
Table 1: Materials Used For Losartan Potassium Microspheres 
S. No Chemical Name Supplier 
1 Losartan Potassium Micro labs, Pvt, Ltd Bengaluru (Gift Sample) 
4 Sodium Alginate Lobachemi, Pvt Ltd.Mumbai 
5 HPMC K 100 Lobachemi, Pvt Ltd.Mumbai 
7 Ethonol S.D fine chemicals Pvt Ltd, Mumbai 
8 Methenol S.D fine chemicals Pvt Ltd, Mumbai 
9 Dichloromethane Merck Pvt Ltd, Mumbai 
10 Conc.HCL Nice chemicals, Pvt Ltd, Cochin 
11 Tween 80 S.D fine chemicals Pvt Ltd, Mumbai 
 
Equipments  
Table 2: Equipment Used For Losartan Potassium Microspheres 
S.No Name of the Equipment Supplier 
1 Pippetes,Beakers Borosil 
2 Hot air oven Sunbim manfacture Pvt. Ltd 
3 Uv-spectro photo meter Shimadzu 
4 Dissolution apparatus Electro lab 
5 Magnetic stirrer Sunsim, India 
6 PH meter Elico 
7 Scanning eletron microscopy JEOL, JSM-670F,Japan 
8 sieve Jayanth scientific IND, Mumbai 
9 FT –IR apparatus Shimadzu 
 
Methodology 
1. Preformulation Studies 
A. FT-IR Studies4: 
The FT-IR spectrum of pure Losartan, sodium alginate, 
HPMC K 100 was studied. The physical mixtures of the 
floating microspheres formulation also were recorded. 
2.  Formulation of Losartan Potassium Floating 
Microspheres 
Losartan Potassium loaded Floating Microspheres were 
prepared by solvent evaporation technique. HPMC K100 and 
Sodium alginate was dissolved in a mixture of ethanol and 
dichloromethane (1:1) at room temperature. Losartan 
Potassium was added to above solution and then it was 
stirred on a magnetic stirrer to form a homogenous solution. 
Then the above solution was poured into 100 ml of water 
containing 0.01% Tween 80 maintained at room 
temperature. The mixture was stirred for three hour. The 
microspheres were separated by filtration and then dried at 
room temperature. Formulation plan described in Following 
Table.
 
Table 3: (a): Levels and the experimental condition for the 32 factorial design 
S.no.                Factors Low level 
(-) 
Mid level 
(0) 
High level 
(+) 
  1 
Polymer concentration  
(Sodium alginate : HPMC K100) (%w/v) 
0.25:0.50 0.37:0.75 0.5:1.00 
  2 Solvent ratio Ethanol : Dichloromethane (%v/v) 1:1 1.5:1 2:1 
Table 3: (b): Formulation of microsphere by implementing 32 factorial designs 
Formulation code  X1 (Independent Variable) X2 (Independent Variable) 
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Actual Value Code value Actual Value Code value 
LP1 0.25:0.50 -1 1 : 1 -1 
LP2 0.25:0.50 -1   1.5 : 1 0 
LP3 0.25:0.50 -1 2 : 1 1 
LP4 0.37:0.75 0 1 : 1 -1 
LP5 0.37:0.75 0   1.5 : 1 0 
LP6 0.37:0.75 0 2 : 1 1 
LP7 0.5:1.00 1 1 : 1 -1 
LP8 0.5:1.00 1   1.5 : 1 0 
LP9 0.5:1.00 1 2 : 1 1 
X1= Polymer concentration (Sodium alginate: HPMC K100) (%w/v) 
X2=Solvent ratio Ethanol: Dichloromethane (%v/v) 
 
Table 4: Optimization of Losartan microsphere formulation by implementing three level two factor factorial design 
Formulation      
    code 
Drug 
(mg) 
Effect of Independent 
variables (X) 
Responses of dependent variables (Y) 
X1 
(% w/v) 
X2 
(% v/v) 
Y1 
(Particle 
size                 
in µm) 
Y2 
(% 
Buoyancy) 
Y3 
(% Drug 
entrapment) 
Y4 
(% Drug 
release) 
LP1 500 0.25 : 0.50 1 : 1 675±11.13 68.98±1.26 55.2±0.21 97.03±1.92* 
LP2 500 0.25 : 0.50 1.5 : 1 677±12.43 70.89±1.53 55.6±0.31 95.01±1.19* 
LP3 500 0.25 : 0.50 2 : 1 689±11.45 69.12±1.62 56.1±0.34 93.31±1.02* 
LP4 500 0.37 : 0.75 1 : 1 690±11.76 73.62±1.33 56.7±0.64 98.91±1.01** 
LP5 500 0.37 : 0.75 1.5 : 1 710±11.32 76.56±1.20 58.3±0.29 97.09±1.20** 
LP6 500 0.37 : 0.75 2 : 1 723±11.33 75.15±1.73 58.6±0.27 96.71±1.06** 
LP7 500 0.5 : 1.00 1 : 1 740±11.92 84.87±1.25 66.2±0.28 98.34±1.03*** 
LP8 500 0.5 : 1.00 1.5 : 1 745±10.32 80.23±1.24 61.2±0.22 95.12±1.06*** 
LP9 500 0.5 : 1.00 2 : 1 772±12.11 82.98±1.63 59.2±0.26 93.34±1.09*** 
Note:-    * - Drug release completed in 16 hrs              ** - Drug release completed in 20 hrs          *** - Drug release completed in 24 hrs  
 
3.  EvaluationTests:5 
The following parameters are determined for floating 
microspheres of Losartan Potassium  
Drug Entrapment:6 
The various formulations of the floating microspheres were 
subjected for drug content. 100mg of floating microspheres 
from all batches were accurately weighed. The microspheres 
were dissolved with 10ml ethanol in in 100ml volumetric 
flask and make up the volumewith1.2 pH acidic buffer. The 
resulting solution is then filtered through whatmann filter 
paper no 44. after filtration, from the solution 10ml was 
taken out and diluted up to 100ml with pH1.2 .again from the 
solution taken out and diluted up to 10ml with pH1.2 and the 
absorbance was measured at 362nm against pH1.2 as blank. 
The percentage drug entrapment was calculated as follows. 
 
Particle size analysis: 7,8 
Particle size analysis plays an important role in determining 
the release characteristic and floating property. The size of 
floating microspheres were measured by using an optical 
microscope, and the mean practical size was calculated by 
measuring nearly 200 particles with the help of calculated 
ocularmicrometer. 
Percentage yield9: 
The prepared microspheres weighed from different 
formulations the measured weight was divided by the total 
amount of all non -volatile components which were used for 
the preparation of microspheres. 
 
Buoyancy percentage: 10 
100 mg of floating microspheres were placed in pH1.2 
(900ml) containing 0.02% of tween80.the mixture was 
stirred with paddle at 100 rpm. The layer of buoyant 
microsphere was pippeted and separated by filtration at 1, 2, 
4, 6, 10, 16 and 24 hrs the collected microspheres were dried 
in desiccators over night. The percentage of microspheres 
was calculated by the following equation: 
 
Scanning electron microscopy:11 
Dry microspheres were placed on an electron microscope 
brass stub coated with gold in an ion sputter.Then picture of 
microsphere were taken by random scanning of stub. The 
SEM analysis of the microspheres was carried out by using 
JEOL, JSM-670F japan (Sastra University, tanjavur).the 
microspheres were viewed at an accelerating voltage of 3.0. 
In-Vitro Drug release studies:12 
The drug release rate from floating microspheres was 
carried out using the USP type – II dissolution basket 
assembly. A weighed amount of floating microspheres 
equivalent to 100 mg drug were discrete in 900 ml of pH1.2 
maintained at 37±0.5 ºC and stirred at 50 rpm. 1ml sample 
was withdrawn at predetermined intervals and filtered and 
equal volume of dissolution medium replaced in the vessel 
after each withdrawal to maintain sink condition. The 
collected samples were suitably diluted with pH 1.2 and 
analyzed spectrophtometrically at specific wavelengths to 
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determine the concentration of drug present in the 
dissolution medium. 
Details of dissolution test: 
1. Apparatus   : USP type II 
2. Volume of medium  : 900 ml 
3. Temperature   : 37 ± 0.5 °C 
4. Paddle speed   : 50 rpm 
5. Dissolution medium used: 0.1 N HCl containing 0.02% 
tween 20 
6. Aliquot taken at each time interval: 10 ml 
RESULT AND DISCUSSION 
Drug Entrapment 
The drug entrapment efficacies of different formulations 
were in range of 55.2 - 64.2%w/w.as shown in the figure 1. 
Drug entrapment efficacy slightly decreased with increase 
HPMC K100 content ratio in microspheres. This is due to the 
permeation characteristic of HPMC K100 that could facilitate 
diffusion of part of entrapped drug to surrounding medium 
during preparation of floating microspheres.  
 
Figure 1: Drug Entrapment 
Particle Size Analysis: 
The particle size was determined by optical microscopy 
method. It plays an important role in floating ability and 
drug release. 
Microspheres ranges between 500µm - 1000µm, the floating 
ability will be more and release rate will be in sustaining 
manner. 
The mean particle size of microspheres was in range 675-
772 µm. The results were shown in the figure 2. The particle 
size distribution was almost uniform and narrow in all the 
formulations.  
 
 
Figure 2: Particle Size Analysis 
Percentage Yield: 
The percentage yield of different formulation was 
determined by weighing the microspheres after drying. The 
percentage yield of developed formulations of Losartan 
Potassium floating microspheres LP1-LP9 were found to be 
in the range of 53.7 -78.3%. 
 
 
Figure 3: Percentage Yield 
 
 
 
 
 
 
 
 
 
 
 
0 
10 
20 
30 
40 
50 
60 
70 
LP1 LP2 LP3 LP4 LP5 LP6 LP7 LP8 LP9 
% Drug Entrapment 
Drug Entrapment 
0 
100 
200 
300 
400 
500 
600 
700 
800 
900 
LP1 LP2 LP3 LP4 LP5 LP6 LP7 LP8 LP9 
Particle Size  
Particle Size  
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
LP1 LP2 LP3 LP4 LP5 LP6 LP7 LP8 LP9 
Percentage Yield 
Percentage Yield 
Purohit et al                                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(1-s):60-66 
ISSN: 2250-1177                                                                                  [64]                                                                                 CODEN (USA): JDDTAO 
Floating behavior of Losartan Potassium Microspheres: 
 
Figure 4: Floating behavior of Losartan Potassium 
Microspheres (All Formulations) 
Scanning Electronic Microscopy: 
Shape and surface characteristics of microspheres were 
examined by Scanning Electron Microscopy. Surface 
morphology of LP7 formulation was examined at an different 
magnification of 100X and 500X, which illustrate the smooth 
surface of floating microspheres and small hollow cavity 
present in microspheres which is responsible for floating 
property. SEM revealed pores on the microsphere as well as 
hollow microsphere interior. The surface morphology 
internal structure of microspheres was determined by SEM 
as shown in figure 5. From this figure it was observed that so 
many pores are formed due to the drug release. Some pores 
may be small on big in size due to the blasting of the drug. 
 
Figure 5: Scanning Electronic Microscopy of Losartan 
Potassium Microspheres 
In-vitro Drug Release Profile of Losartan Potassium 
Microspheres:- 
The drug release data obtained for the formulations from 
LP1 –LP9 were shown in figure 6. The in-vitro release studies 
of the floating microspheres were studied for all the 
formulations.
  
 
 
Figure 6: In-vitro Drug Release from Losartan Potassium Microspheres (All Formulations) 
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Table 5: Optimization of Release at 24th Hr 
Regression Statistics 
Multiple R 0.9995927 
R Square 0.9983858 
Adjusted R Square 0.996462 
Standard Error 0.6976513 
Observations 9 
 
Table 6: Analysis of variance 
ANOVA 
 Degree of 
Freedom 
Sum 
Square 
Mean 
Square 
F Significance 
F 
Regression 5 1152.1262 246.42524 499.53559 0.0001835 
Residual 3 1.6592891 0.5730964   
Total 8 1181.5755    
 
 
Figure 7: Contour Plot for Particle Size after Optimization 
 
 
Figure 8: Contour Plot for Buoyancy after Optimization 
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Figure 9: Contour Plot for % Drug Entrapment after Optimization 
 
Figure 10: Contour Plot for % Drug Release after Optimization 
 
CONCLUSION 
It can be concluded that Floating Microspheres of Losartan 
potassium were formed by Solvent Evaporation method .The 
formulas LP7 of Losartan Potassium Floating Microspheres 
shows a very good drug release profiles and shown better 
sustained action till the end of last hour (24th hrs). It will 
improve patient compliance and increase in bioavailability 
which give better approach to treat hypertensive condition 
and the angiotensin receptor blocking action of Losartan 
lower the long term complications of Hypertension and 
reduce the risk of heart failure, CHF, Myocardial Infarction 
and also vascular damage in blood vessels and kidney. 
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